PSFG
IDXX icon

Park Square Financial Group’s Idexx Laboratories IDXX Stock Holding History

Park Square Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-32
Closed -$17.2K – 582
2025
Q2 		$17.2K Hold
32
– – 0.01% 498
2025
Q1 		$13.4K Hold
32
– – 0.01% 531
2024
Q4 		$13.2K Buy
+32
New +$14K 0.01% 526

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Park Square Financial Group's IDXX Position: Q3 2025 in Review

Park Square Financial Group sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 32 shares — an estimated $17.2K sold.

Park Square Financial Group first reported a position in IDXX in Q4 2024 and held it in 3 quarters. The position peaked at $17.2K in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Park Square Financial Group reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Park Square Financial Group sold 32 Idexx Laboratories shares in Q3 2025, an estimated $17.2K.
  • Park Square Financial Group first reported a position in Idexx Laboratories in Q4 2024 and held it in 3 quarters.
  • Park Square Financial Group's Idexx Laboratories position peaked at $17.2K in Q2 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Park Square Financial Group's 13F filing for Q3 2025, filed 12 Nov 2025.